PAMELOR: NORTRIPTYLINE HYDROCHLORIDE CAPS.
NORTRIPTYLINE HYDROCHLORIDE CAPS. Key specifications include special_features: UNIT DOSE; PACKAGES OF INDIVIDUALLY BLISTER-SEALED CAPSULES, capsule_content_form: POWDER, primary_container_type: BOX, therapeutic_equivalent: PAMELOR BY SANDOZ PHARMACEUTICALS, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, active_medicament_medicinal_strength: 50.000 MILLIGRAMS NORTRIPTYLINE HYDROCHLORIDE ACTIVE INGREDIENT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-083-5987, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | UNIT DOSE; PACKAGES OF INDIVIDUALLY BLISTER-SEALED CAPSULES |
| capsule_content_form | POWDER |
| primary_container_type | BOX |
| therapeutic_equivalent | PAMELOR BY SANDOZ PHARMACEUTICALS |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 1 |
| active_medicament_medicinal_strength | 50.000 MILLIGRAMS NORTRIPTYLINE HYDROCHLORIDE ACTIVE INGREDIENT |
| general_characteristics_item_description | STERILE; PINT BOTTLE; 10 MG. NORTRIPTYLINE HYDROCHLORIDE PER 5 ML. |
| part_name_assigned_by_controlling_agency | NORTRIPTYLINE HYDROCHLORIDE CAPSULES USP 75MG 100S BT |
| capsule_primary_container_content_quantity | 100.000 |
| NSN | 6505-01-083-5987 |
| THERAPEUTIC EQUIVALENT | PAMELOR BY SANDOZ PHARM.,CORP. |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | 10 MG NORTRIPTYLINE EQUIVALENT |
| CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 100.000 |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | NORTRIPTYLINE HYDROCHLORIDE CAPSULES USP 10MG 100S BT |
| CAPSULE CONTENT FORM | POWDER |